Introducing Delaware Bio's Board of Directors

Delaware Bio's board is dedicated to ensuring the success of the life science industry in the state of Delaware and the surrounding region ultimately, helping businesses not only survive, but thrive driving innovation in the First State's economy.

OFFICERS

C_Yochim

Chris Yochim

Chairman

H_Stimson

Helen Stimson

President & CEO

M_Bowman

Mike Bowman

Treasurer

P_Amoa

Philip D. Amoa

Secretary

BOARD OF DIRECTORS

I_Bahar

Izak Bahar

Vice President, R&D Assay Development

Siemens Healthineers

Mark Brainard 270

Mark T. Brainard, Ph.D.

President

Delaware Technical Community College

P_Cannon

Patricia A. Cannon, MSM, ASZ

Director of Development & FTZ #99 Grantee Administrator

 Delaware Department of State

R_Dashefsky

Richard Dashefsky

Senior Counsel

Christiana Care

Fran_DiNuzzo

Fran DiNuzzo

President & CEO

ILC Dover

K_Griffin

Kristin Giffin

Vice President of Operations, Quality, and Support

Agilent Technologies

B_Hsu

T. Ben Hsu, Ph.D.

Chief Administrative Officer

QPS Holdings, LLC

K_Lee

Kelvin Lee, Ph.D.

Institute Director

Manufacturing USA National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

W_Mongan

William Mongan

Vice President U.S. Business Development, New Product

Planning, and Foundations Brands

AstraZeneca Pharmaceuticals LP

P_Murphy

Pamela Murphy

Vice President Investor Relations & Corporate Communications (ret),

Incyte Corporation

Paula Swain 270

Paula J. Swain

Executive Vice President of Human Resources

Incyte Corporation 

G_Tronto

Greg Tronto

Gore PharmBio Product Business Development Leader, Drug Delivery

W. L. Gore & Associates, Inc.

r_Yin

Ray Yin, Ph.D.

President

ANP Technologies, Inc.

pICTURE COMING SOON:

Blank_silhouette

Venu (Kal) Kalavacharla, Ph.D.

Professor, Molecular Genetics and Genomics & Director,

Center for Integrated Biological & Environmental Research (CIBER), Delaware State University